Stay updated on ARGX-110 with Azacytidine in AML Clinical Trial

Sign up to get notified when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARGX-110 with Azacytidine in AML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-25T16:31:29.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-11T07:55:28.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-04T04:00:01.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T23:10:20.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2025-02-17T19:30:14.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T16:38:12.000Z thumbnail image

Stay in the know with updates to ARGX-110 with Azacytidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.